NCT05359055View on ClinicalTrials.gov

Drug-drug Interaction Study of SPH3127

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

January 21, 2022

Study Completion Date

January 21, 2022

Conditions
Drug Drug Interaction
Interventions
DRUG

SPH3127 tablet

100mg once daily on Day 1 and Day 8

DRUG

Itraconazole

200mg once daily from Day 3 to Day10.

DRUG

SPH3127 tablet

200mg once daily on Day 1 and Day 12.

DRUG

Rifampin

600mg once daily from Day 3 to Day13.

Trial Locations (1)

610044

West China Second University Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

NCT05359055 - Drug-drug Interaction Study of SPH3127 | Biotech Hunter | Biotech Hunter